We are thrilled to enter into a definitive agreement with Kalaris and see an opportunity to work with the Kalaris team to bring their innovative investigational anti-VEGF treatment, TH103, to help patients suffering from vision-impairing retinal diseases. We look forward to working with the veteran Kalaris team in the coming months. Read the full press release here: https://lnkd.in/eEPJUvhU
AlloVir
Biotechnology Research
Waltham, MA 9,015 followers
A global leader in allogeneic, off-the-shelf, multi-virus specific T- cell immunotherapies
About us
AlloVir, formerly ViraCyte, was founded in 2013 and is the leader in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems. The company’s technology platforms deliver commercially scalable solutions by leveraging off-the-shelf, allogeneic, multi-virus specific T cells targeting devastating viral pathogens for immunocompromised patients under viral attack. AlloVir’s technology and manufacturing process enables the potential for the treatment and/or prevention of up to six devastating viruses with each single allogeneic cell therapy. The company is advancing multiple mid- and late-stage clinical trials across its product portfolio.
- Website
-
http://www.allovir.com
External link for AlloVir
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Waltham, MA
- Type
- Public Company
- Specialties
- Cell Therapy, Infectious disease, Therapeutic developer, and Biotechnology
Locations
-
Primary
Get directions
1100 Winter Street
Waltham, MA 02451, US
-
Get directions
2925 Richmond Ave
Suite 1200
Houston, Texas 77098, US
Employees at AlloVir
Updates
-
Today AlloVir announced that it will stop three ongoing Phase 3 trials of its lead multi-virus-specific T cell therapy, posoleucel, for futility. Learn more here: https://lnkd.in/eZ7NWu3A
-